📖

In Alzheimer's disease, biomarker events occur in a specific temporal sequence: amyloid-β abnormalit

wiki page Created: 2026-04-02 22:04:50 By: crosslink-expanded Quality: 50% ✓ SciDEX ID: wiki-hypotheses-alzheimers-disease-bioma
📅 Version Timeline 2 versions
Version Details
v1
Current Version
Compare: with
Related Entities
hypotheses-alzheimers-disease-biomarker-events-occur
Metadata
slughypotheses-alzheimers-disease-biomarker-events-occur
entity_typehypothesis
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (113)
mentions🧪Netrin-1 Gradient Restoration55%
mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 55%
mentions🧪Ganglioside Rebalancing Therapy55%
mentions🧪Mitochondrial RNA Granule Rescue Pathway55%
mentions🧪Multi-Modal Stress Response Harmonization55%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade55%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi55%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones55%
mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics55%
mentions🧪Prefrontal sensory gating circuit restoration via PV interne55%
mentions🧪Ocular Immune Privilege Extension55%
mentions🧪Hypocretin-Neurogenesis Coupling Therapy55%
mentions🧪Gut Barrier Permeability-α-Synuclein Axis Modulation55%
mentions🧪Lipid Droplet Dynamics as Phenotype Switches55%
mentions🧪Circadian-Synchronized LRP1 Pathway Activation55%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In55%
mentions🧪Orexin-Microglia Modulation Therapy55%
mentions🧪Sleep Spindle-Synaptic Plasticity Enhancement55%
mentions🧪Lysosomal Calcium Channel Modulation Therapy55%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization55%
mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati55%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation55%
mentions🧪Digital Twin-Guided Metabolic Reprogramming55%
mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)55%
mentions🧪Nucleolar Stress Response Normalization55%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi50%
mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau50%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪APOE Isoform Conversion Therapy50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
mentions🧪APOE-TREM2 Interaction Modulation50%
mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%
mentions🧪TREM2-Dependent Microglial Senescence Transition50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
related🧫s:** - Test whether HCN1 knockout specifically in EC layer I50%
related🧫Proposed experiment from debate on Synaptic pruning by micro50%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD50%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 50%
related🧫4R-Tau Targeting Therapies for PSP and CBS50%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi50%
related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau50%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti50%
related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?50%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap50%
related🧫Anti-Tau Immunotherapy Dosing Optimization50%
related🧫ApoE4 Function in Alzheimer's Disease50%
related🧫Experiment: Autoimmune Hypothesis Testing in AD50%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration50%
related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#50%
related🧫Blood-Based Biomarker Panel for Early AD Detection50%
related🧫tACS Connectivity Trial in Early Alzheimer's50%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD50%
related🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 50%
related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M50%
related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera50%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera50%
related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa50%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation50%
related🧫Gap Junction Dysfunction Validation in Parkinson's Dise50%
related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas50%
related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise50%
related🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech50%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr50%
related🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis50%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress50%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease50%
related🧫Normal Aging to Alzheimer's Disease Transition Trigger 50%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 50%
related🧫Prion Strain Diversity and Selective Vulnerability50%
related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease50%
related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#50%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and50%
related🧫Sleep Disruption and Alzheimer's Disease — mechanism an50%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation50%
related🧫Experiment Validation: In vitro ThT Assay50%
related🧫Tau ASO Therapy50%
related🧫Microglial TREM2 Agonist In Vivo Efficacy50%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia50%
related🧫Vascular Contribution to Alzheimer's Disease — Beyond A50%
related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol50%
related🧫Viral Infections and Alzheimer's Disease — causal mecha50%
mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease44%
mentions🧫Creation and validation of 3xAD-ChAT-Cre mouse model44%
mentions🧫Adoptive transfer of TCRAβ-Tregs in AD mouse model44%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
related🔬What are the mechanisms underlying selective vulnerability o38%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp38%
related🔬What are the mechanisms underlying astrocyte reactivity subt38%
related🔬What are the mechanisms underlying blood-brain barrier trans38%
related🔬What are the mechanisms underlying apoe4 structural biology 38%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa38%
related🔬What are the mechanisms underlying digital biomarkers and ai38%
related🔬What are the mechanisms underlying neuroinflammation resolut38%
related🔬What are the mechanisms underlying what are the mechanisms b38%
related🔬What are the mechanisms underlying mitochondrial transfer be38%
related🔬What are the mechanisms underlying mechanistic role of apoe 38%
related🔬Investigate how lipid raft composition (cholesterol metaboli38%
related🔬What are the mechanisms underlying sleep disruption as cause38%
related🔬What are the mechanisms underlying rna binding protein dysre38%
related🔬What are the mechanisms underlying synaptic pruning by micro38%
related🔬What are the mechanisms underlying perivascular spaces and g38%
related🔬Analyze circuit-level changes in neurodegeneration using All38%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di38%
related🔬Epigenetic reprogramming in aging neurons38%
related🔬How does metabolic reprogramming (glucose metabolism shifts,38%

💬 Discussion